Home > > > > > Report Detail

Global Lung Cancer Therapeutics Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 14-Apr-2020
No. of pages: 116

According to this study, over the next five years the Lung Cancer Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Lung Cancer Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Lung Cancer Therapeutics market by type, application, key companies and key regions.

This study considers the Lung Cancer Therapeutics value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Targeted Therapy

- Immunotherapy

- Chemotherapy

- Radiation Therapy

- Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Non-Small Cell Lung Cancer (NSCLC)

- Small Cell Lung Cancer (SCLC)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- AstraZeneca

- Agennix AG

- Eli Lilly and Company

- Roche

- Boehringer Ingelheim GmbH

- GlaxoSmithKline

- Bristol-Myers Squibb

- Pfizer

- Novartis

- Sanofi S.A.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Lung Cancer Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Lung Cancer Therapeutics market by identifying its various subsegments.

- Focuses on the key global Lung Cancer Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Lung Cancer Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Lung Cancer Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Lung Cancer Therapeutics Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Therapeutics Market Size 2015-2025
2.1.2 Lung Cancer Therapeutics Market Size CAGR by Region
2.2 Lung Cancer Therapeutics Segment by Type
2.2.1 Targeted Therapy
2.2.2 Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Radiation Therapy
2.2.5 Others
2.3 Lung Cancer Therapeutics Market Size by Type
2.3.1 Global Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
2.3.2 Global Lung Cancer Therapeutics Market Size Growth Rate by Type (2015-2020)
2.4 Lung Cancer Therapeutics Segment by Application
2.4.1 Non-Small Cell Lung Cancer (NSCLC)
2.4.2 Small Cell Lung Cancer (SCLC)
2.5 Lung Cancer Therapeutics Market Size by Application
2.5.1 Global Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
2.5.2 Global Lung Cancer Therapeutics Market Size Growth Rate by Application (2015-2020)

3 Global Lung Cancer Therapeutics by Players
3.1 Global Lung Cancer Therapeutics Market Size Market Share by Players
3.1.1 Global Lung Cancer Therapeutics Market Size by Players (2018-2020)
3.1.2 Global Lung Cancer Therapeutics Market Size Market Share by Players (2018-2020)
3.2 Global Lung Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Lung Cancer Therapeutics by Regions
4.1 Lung Cancer Therapeutics Market Size by Regions
4.2 Americas Lung Cancer Therapeutics Market Size Growth
4.3 APAC Lung Cancer Therapeutics Market Size Growth
4.4 Europe Lung Cancer Therapeutics Market Size Growth
4.5 Middle East & Africa Lung Cancer Therapeutics Market Size Growth

5 Americas
5.1 Americas Lung Cancer Therapeutics Market Size by Countries
5.2 Americas Lung Cancer Therapeutics Market Size by Type
5.3 Americas Lung Cancer Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Lung Cancer Therapeutics Market Size by Regions
6.2 APAC Lung Cancer Therapeutics Market Size by Type
6.3 APAC Lung Cancer Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Lung Cancer Therapeutics by Countries
7.2 Europe Lung Cancer Therapeutics Market Size by Type
7.3 Europe Lung Cancer Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Therapeutics by Countries
8.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Type
8.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Lung Cancer Therapeutics Market Forecast
10.1 Global Lung Cancer Therapeutics Market Size Forecast (2021-2025)
10.2 Global Lung Cancer Therapeutics Forecast by Regions
10.2.1 Global Lung Cancer Therapeutics Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Lung Cancer Therapeutics Forecast by Type
10.8 Global Lung Cancer Therapeutics Forecast by Application

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 Company Details
11.1.2 Lung Cancer Therapeutics Product Offered
11.1.3 AstraZeneca Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 AstraZeneca News
11.2 Agennix AG
11.2.1 Company Details
11.2.2 Lung Cancer Therapeutics Product Offered
11.2.3 Agennix AG Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Agennix AG News
11.3 Eli Lilly and Company
11.3.1 Company Details
11.3.2 Lung Cancer Therapeutics Product Offered
11.3.3 Eli Lilly and Company Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Eli Lilly and Company News
11.4 Roche
11.4.1 Company Details
11.4.2 Lung Cancer Therapeutics Product Offered
11.4.3 Roche Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Roche News
11.5 Boehringer Ingelheim GmbH
11.5.1 Company Details
11.5.2 Lung Cancer Therapeutics Product Offered
11.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Boehringer Ingelheim GmbH News
11.6 GlaxoSmithKline
11.6.1 Company Details
11.6.2 Lung Cancer Therapeutics Product Offered
11.6.3 GlaxoSmithKline Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 GlaxoSmithKline News
11.7 Bristol-Myers Squibb
11.7.1 Company Details
11.7.2 Lung Cancer Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Bristol-Myers Squibb News
11.8 Pfizer
11.8.1 Company Details
11.8.2 Lung Cancer Therapeutics Product Offered
11.8.3 Pfizer Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Pfizer News
11.9 Novartis
11.9.1 Company Details
11.9.2 Lung Cancer Therapeutics Product Offered
11.9.3 Novartis Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Novartis News
11.10 Sanofi S.A.
11.10.1 Company Details
11.10.2 Lung Cancer Therapeutics Product Offered
11.10.3 Sanofi S.A. Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Sanofi S.A. News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Lung Cancer Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Radiation Therapy
Table 8. Major Players of Others
Table 9. Lung Cancer Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table 10. Global Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Table 11. Global Lung Cancer Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
Table 13. Global Lung Cancer Therapeutics Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Lung Cancer Therapeutics Revenue Market Share by Players (2018-2020)
Table 15. Global Lung Cancer Therapeutics Key Players Head office and Products Offered
Table 16. Lung Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Lung Cancer Therapeutics Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Lung Cancer Therapeutics Market Size Market Share by Regions 2015-2020
Table 21. Americas Lung Cancer Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Lung Cancer Therapeutics Market Size Market Share by Countries (2015-2020)
Table 23. Americas Lung Cancer Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Table 25. Americas Lung Cancer Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
Table 27. APAC Lung Cancer Therapeutics Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Lung Cancer Therapeutics Market Size Market Share by Regions (2015-2020)
Table 29. APAC Lung Cancer Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Table 31. APAC Lung Cancer Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
Table 33. Europe Lung Cancer Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Lung Cancer Therapeutics Market Size Market Share by Countries (2015-2020)
Table 35. Europe Lung Cancer Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Table 37. Europe Lung Cancer Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Lung Cancer Therapeutics Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Lung Cancer Therapeutics
Table 46. Key Application and Potential Industries of Lung Cancer Therapeutics
Table 47. Key Challenges of Lung Cancer Therapeutics
Table 48. Key Trends of Lung Cancer Therapeutics
Table 49. Global Lung Cancer Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Lung Cancer Therapeutics Market Size Market Share Forecast by Regions
Table 51. Global Lung Cancer Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global Lung Cancer Therapeutics Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global Lung Cancer Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Lung Cancer Therapeutics Market Size Market Share Forecast by Application (2021-2025)
Table 55. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 56. AstraZeneca Lung Cancer Therapeutics Product Offered
Table 57. AstraZeneca Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Latest Developments
Table 60. Agennix AG Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 61. Agennix AG Lung Cancer Therapeutics Product Offered
Table 62. Agennix AG Main Business
Table 63. Agennix AG Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 64. Agennix AG Latest Developments
Table 65. Eli Lilly and Company Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 66. Eli Lilly and Company Lung Cancer Therapeutics Product Offered
Table 67. Eli Lilly and Company Main Business
Table 68. Eli Lilly and Company Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 69. Eli Lilly and Company Latest Developments
Table 70. Roche Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 71. Roche Lung Cancer Therapeutics Product Offered
Table 72. Roche Main Business
Table 73. Roche Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 74. Roche Latest Developments
Table 75. Boehringer Ingelheim GmbH Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 76. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product Offered
Table 77. Boehringer Ingelheim GmbH Main Business
Table 78. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 79. Boehringer Ingelheim GmbH Latest Developments
Table 80. GlaxoSmithKline Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 81. GlaxoSmithKline Lung Cancer Therapeutics Product Offered
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 84. GlaxoSmithKline Latest Developments
Table 85. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 86. Bristol-Myers Squibb Lung Cancer Therapeutics Product Offered
Table 87. Bristol-Myers Squibb Main Business
Table 88. Bristol-Myers Squibb Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 89. Bristol-Myers Squibb Latest Developments
Table 90. Pfizer Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 91. Pfizer Lung Cancer Therapeutics Product Offered
Table 92. Pfizer Main Business
Table 93. Pfizer Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 94. Pfizer Latest Developments
Table 95. Novartis Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 96. Novartis Lung Cancer Therapeutics Product Offered
Table 97. Novartis Main Business
Table 98. Novartis Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 99. Novartis Latest Developments
Table 100. Sanofi S.A. Details, Company Total Revenue (in $ million), Head Office, Lung Cancer Therapeutics Major Market Areas and Its Competitors
Table 101. Sanofi S.A. Lung Cancer Therapeutics Product Offered
Table 102. Sanofi S.A. Main Business
Table 103. Sanofi S.A. Lung Cancer Therapeutics Revenue and Gross Margin (2018-2020E)
Table 104. Sanofi S.A. Latest Developments

List of Figures

Figure 1. Lung Cancer Therapeutics Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Lung Cancer Therapeutics Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Lung Cancer Therapeutics Market Size Market Share by Type (2015-2020)
Figure 5. Global Targeted Therapy Market Size Growth Rate
Figure 6. Global Immunotherapy Market Size Growth Rate
Figure 7. Global Chemotherapy Market Size Growth Rate
Figure 8. Global Radiation Therapy Market Size Growth Rate
Figure 9. Global Others Market Size Growth Rate
Figure 10. Lung Cancer Therapeutics in Non-Small Cell Lung Cancer (NSCLC)
Figure 11. Global Lung Cancer Therapeutics Market: Non-Small Cell Lung Cancer (NSCLC) (2015-2020) ($ Millions)
Figure 12. Lung Cancer Therapeutics in Small Cell Lung Cancer (SCLC)
Figure 13. Global Lung Cancer Therapeutics Market: Small Cell Lung Cancer (SCLC) (2015-2020) ($ Millions)
Figure 14. Global Lung Cancer Therapeutics Market Size Market Share by Application in 2019
Figure 15. Global Lung Cancer Therapeutics Market Size Market Share by Regions 2015-2020
Figure 16. Americas Lung Cancer Therapeutics Market Size 2015-2020 ($ Millions)
Figure 17. APAC Lung Cancer Therapeutics Market Size 2015-2020 ($ Millions)
Figure 18. Europe Lung Cancer Therapeutics Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa Lung Cancer Therapeutics Market Size 2015-2020 ($ Millions)
Figure 20. Americas Lung Cancer Therapeutics Market Size Market Share by Countries in 2019
Figure 21. Americas Lung Cancer Therapeutics Market Size Market Share by Type in 2019
Figure 22. Americas Lung Cancer Therapeutics Market Size Market Share by Application in 2019
Figure 23. United States Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC Lung Cancer Therapeutics Market Size Market Share by Regions in 2019
Figure 27. APAC Lung Cancer Therapeutics Market Size Market Share by Type in 2019
Figure 28. APAC Lung Cancer Therapeutics Market Size Market Share by Application in 2019
Figure 29. China Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 33. India Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe Lung Cancer Therapeutics Market Size Market Share by Countries in 2019
Figure 36. Europe Lung Cancer Therapeutics Market Size Market Share by Type in 2019
Figure 37. Europe Lung Cancer Therapeutics Market Size Market Share by Application in 2019
Figure 38. Germany Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 39. France Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa Lung Cancer Therapeutics Market Size Market Share by Application in 2019
Figure 47. Egypt Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries Lung Cancer Therapeutics Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global Lung Cancer Therapeutics arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 54. APAC Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 55. Europe Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 57. United States Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 58. Canada Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 59. Mexico Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 60. Brazil Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 61. China Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 62. Japan Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 63. Korea Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 65. India Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 66. Australia Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 67. Germany Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 68. France Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 69. UK Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 70. Italy Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 71. Russia Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 72. Spain Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 73. Egypt Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 74. South Africa Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 75. Israel Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 76. Turkey Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries Lung Cancer Therapeutics Market Size 2021-2025 ($ Millions)
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs